Effectiveness of ursodeoxycholic acid associated silymarin in the treatment of chronic athrylic hepatopathy;Impiego dell'acido ursodesossicolico associato alla silimarina nel trattamento della epatopatia cronica etiltossica

Clinica Terapeutica

Volumn 153, Issue 5, 2002, Pages 305-307

  Bettini, Roberto ^a,b   Gorini, M ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Ethylic hepatopathy; Silymarin; Ursodeoxycholic acid

Indexed keywords

CHENODEOXYCHOLIC ACID; LIVER ENZYME; LIVER PROTECTIVE AGENT; SILYMARIN; URSODEOXYCHOLIC ACID;

ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; DRUG EFFECT; FOLLOW UP; HUMAN; LIVER FUNCTION; LIVER PROTECTION; TREATMENT OUTCOME;

ADULT; AGED; ANTIOXIDANTS; CHOLAGOGUES AND CHOLERETICS; DRUG THERAPY, COMBINATION; HEPATITIS, ALCOHOLIC; HUMANS; LIVER; MALE; MIDDLE AGED; PROTECTIVE AGENTS; SILYMARIN; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 0036762491     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bindoli, et al.: Sul meccanismo dell'azione antiperossidativa della silimarina sulle membrane biologiche. Epat 23, 5, 220- 225, 1977
2. Bindoli, et al.: Inhibitory action of silymarin of lipid peroxyde formation in rat liver mitocondria ad microsomes. Biochem Pharmacol 26: 2405-2409, 1977
3. Feher J, et al.: Effect of free radical scavengers on superoxide dismutase enzyme in patients with alcoholic cirrhosis. Acta Med Hung 45/3-4: 265-276, 1988
4. 0 Bienn. Meet., Torino, 16-20 Giugno 1992
5. Palasciano G, et al.: The effect of silymarin on plasma levels of malon-dialdehyde in patients receiving long-term treatment with psychotropic drugs. Curr Ther Res 55, 5: 537-545, 1994
6. Pascual C, et al.: Effect of silymarin and silybinin on oxygen radicals. Drug Dev Res 29: 73-77, 1993
7. Podda M, et al.: Ursodeoxycholic acid for chronic liver diseases. J. Clinic. Gastroenterol. 10 (suppl. 2) 25-31, 1988.
8. Puopon R. et al.: Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis ? Lancet 1: 834-836, 1987
9. Roda A, et al.: Structure-activity relationship studies on natural and synthetic bile acid analogs. Dig Dis and Sciences 34, 12: 24-35, 1989
10. Roda, et al.: Bile acids: Physico-chemical properties, function and activity. Ital J Gastroenterology 27: 327-331, 1995
11. Sama C, et al.: Effect of ursodeoxycholic acid on liver tests in chronic hepatitis. Clin Drug Invest 13: 192-198, 1997
12. Valenzuela A, et al.: Inhibitory effect of the flavonoid silymarin on the erytrocyte hemolysis induced by phenilhydrazine. Biochem Bioph Res Comm 126, 2: 712-718, 1985
13. Ward A, et al.: Ursodeoxycholic acid: A review of its pharmacological properties and therapeutic efficacy. Drugs 27: 95-131, 1984